ClinicalTrials.gov
public full text
Public Domain
Pazopanib for Treating Uterine Leiomyosarcoma
The purpose of this study is to test any good and bad effects of the study drug pazopanib.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors#980467
- A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma#1113986
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery#846744
- Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma#1261072
- Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus#848442
Record · ID 1228564
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive